ANDA 65095, held by Hikma. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 65095 (Doxycycline Hyclate), held by Hikma, was first approved by FDA on Jul 2, 2003, with 12 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of Doxycycline Hyclate Tablets and other antibacterial drugs, Doxycycline Hyclate Tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 2, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxycycline HyclateEQ 100MG BASE · tablet;oral | Doxycycline Hyclate | Rx |
| Mar 31, 2025 | Supplement 39Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 18Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 20Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 21Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 24Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 25Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Aug 7, 2023 | Supplement 33Labeling · Standard review | Approved | None posted |
| Jun 25, 2014 | Supplement 14Labeling · Standard review | Approved | |
| Nov 30, 2011 | Supplement 11Labeling | Approved | None posted |
| May 12, 2009 | Supplement 10Labeling | Approved | None posted |
| Jul 2, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters